Substance / Medication

Erlotinib

Overview

Active Ingredient
erlotinib
RxNorm CUI
337525
Labeler: Sun Pharmaceutical Industries, Inc.Updated: 2019-11-06T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

None.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer (NSCLC): A model-based meta-analysis.
Kim MinJung, Ryu Kyongkuk, Kim Heungjo et al. · Comput Biol Med · 2025
PMID: 39862467Meta-Analysis
A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine with erlotinib in the pancreatic cancer.
Yan Longxiang, Lu Wenming, Huang Wenjin et al. · Chin Clin Oncol · 2024
PMID: 39390917Meta-Analysis
Effectiveness and safety of the bevacizumab and erlotinib combinationerlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis.
Motta-Guerrero Rodrigo, Leon Garrido-Lecca Alejandro, Failoc-Rojas Virgilio E et al. · Front Oncol · 2023
PMID: 38322283Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Erlotinib (substance)
SNOMED CT
414123001
UMLS CUI
C1135135
RxNorm CUI
337525
Labeler
Sun Pharmaceutical Industries, Inc.

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.